PhRMA presented Washington with its legislative wish list – and a warning

 

PhRMA presented Washington with its legislative wish list – and a warning that plenty of other countries are trying to woo the industry away from the US.

“Ever more, other countries are recognizing that a long-term commitment to science, technology and biomedical innovation is vital to enabling the biopharmaceutical industry to establish the foundation for economic growth and jobs of the future,” wrote Battelle Technology Partnership Practice in a white paper prepared for the trade group. While the US is still a great place for knowledge-based industries, said the report, “it should be recognized that international competition is rising and retaining US leadership will require the US to not only maintain but expand investments in R&D and commercialization, education, workforce development, financial capital and the nation's science and technology infrastructure, as well as consider overall favorability of the environment for innovation in the USA.”

for more...
http://www.mmm-online.com/phrmas-washington-wish-list/article/242130/